ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-Neprilysin Antibody Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-0P7736
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti Neprilysin Antibody Market Insights Forecast to 2028
BUY CHAPTERS

Global Anti-Neprilysin Antibody Market Research Report 2025

Code: QYRE-Auto-0P7736
Report
July 2025
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bioprojet SCR
Novartis International AG
Pharmaleads SA
Theravance Biopharma Inc
Cipla Ltd
Oceanic Pharmachem Pvt. Ltd

Anti-Neprilysin Antibody Market

The global market for Anti-Neprilysin Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Neprilysin is a neutral endopeptidase and its inhibition increases bioavailability of natriuretic peptides, bradykinin, and substance P, resulting in natriuretic, vasodilatatory, and anti-proliferative effects.
North American market for Anti-Neprilysin Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Anti-Neprilysin Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Anti-Neprilysin Antibody in Hospital Pharmacies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Anti-Neprilysin Antibody include Bioprojet SCR, Novartis International AG, Pharmaleads SA, Theravance Biopharma Inc., Cipla Limited, Oceanic Pharmachem Pvt. Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anti-Neprilysin Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Neprilysin Antibody.
The Anti-Neprilysin Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-Neprilysin Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Neprilysin Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Anti-Neprilysin Antibody Market Report

Report Metric Details
Report Name Anti-Neprilysin Antibody Market
Segment by Type
  • Sacubitril
  • TD-0714
  • STR-324
  • PL-265
  • LHW-090
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bioprojet SCR, Novartis International AG, Pharmaleads SA, Theravance Biopharma Inc., Cipla Limited, Oceanic Pharmachem Pvt. Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Anti-Neprilysin Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-Neprilysin Antibody Market report?

Ans: The main players in the Anti-Neprilysin Antibody Market are Bioprojet SCR, Novartis International AG, Pharmaleads SA, Theravance Biopharma Inc., Cipla Limited, Oceanic Pharmachem Pvt. Ltd

What are the Application segmentation covered in the Anti-Neprilysin Antibody Market report?

Ans: The Applications covered in the Anti-Neprilysin Antibody Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Anti-Neprilysin Antibody Market report?

Ans: The Types covered in the Anti-Neprilysin Antibody Market report are Sacubitril, TD-0714, STR-324, PL-265, LHW-090

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Neprilysin Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Sacubitril
1.2.3 TD-0714
1.2.4 STR-324
1.2.5 PL-265
1.2.6 LHW-090
1.3 Market by Application
1.3.1 Global Anti-Neprilysin Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-Neprilysin Antibody Market Perspective (2020-2031)
2.2 Global Anti-Neprilysin Antibody Growth Trends by Region
2.2.1 Global Anti-Neprilysin Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anti-Neprilysin Antibody Historic Market Size by Region (2020-2025)
2.2.3 Anti-Neprilysin Antibody Forecasted Market Size by Region (2026-2031)
2.3 Anti-Neprilysin Antibody Market Dynamics
2.3.1 Anti-Neprilysin Antibody Industry Trends
2.3.2 Anti-Neprilysin Antibody Market Drivers
2.3.3 Anti-Neprilysin Antibody Market Challenges
2.3.4 Anti-Neprilysin Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Neprilysin Antibody Players by Revenue
3.1.1 Global Top Anti-Neprilysin Antibody Players by Revenue (2020-2025)
3.1.2 Global Anti-Neprilysin Antibody Revenue Market Share by Players (2020-2025)
3.2 Global Anti-Neprilysin Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anti-Neprilysin Antibody Revenue
3.4 Global Anti-Neprilysin Antibody Market Concentration Ratio
3.4.1 Global Anti-Neprilysin Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Neprilysin Antibody Revenue in 2024
3.5 Global Key Players of Anti-Neprilysin Antibody Head office and Area Served
3.6 Global Key Players of Anti-Neprilysin Antibody, Product and Application
3.7 Global Key Players of Anti-Neprilysin Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Neprilysin Antibody Breakdown Data by Type
4.1 Global Anti-Neprilysin Antibody Historic Market Size by Type (2020-2025)
4.2 Global Anti-Neprilysin Antibody Forecasted Market Size by Type (2026-2031)
5 Anti-Neprilysin Antibody Breakdown Data by Application
5.1 Global Anti-Neprilysin Antibody Historic Market Size by Application (2020-2025)
5.2 Global Anti-Neprilysin Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anti-Neprilysin Antibody Market Size (2020-2031)
6.2 North America Anti-Neprilysin Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anti-Neprilysin Antibody Market Size by Country (2020-2025)
6.4 North America Anti-Neprilysin Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-Neprilysin Antibody Market Size (2020-2031)
7.2 Europe Anti-Neprilysin Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anti-Neprilysin Antibody Market Size by Country (2020-2025)
7.4 Europe Anti-Neprilysin Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-Neprilysin Antibody Market Size (2020-2031)
8.2 Asia-Pacific Anti-Neprilysin Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anti-Neprilysin Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific Anti-Neprilysin Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-Neprilysin Antibody Market Size (2020-2031)
9.2 Latin America Anti-Neprilysin Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anti-Neprilysin Antibody Market Size by Country (2020-2025)
9.4 Latin America Anti-Neprilysin Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Neprilysin Antibody Market Size (2020-2031)
10.2 Middle East & Africa Anti-Neprilysin Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anti-Neprilysin Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa Anti-Neprilysin Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bioprojet SCR
11.1.1 Bioprojet SCR Company Details
11.1.2 Bioprojet SCR Business Overview
11.1.3 Bioprojet SCR Anti-Neprilysin Antibody Introduction
11.1.4 Bioprojet SCR Revenue in Anti-Neprilysin Antibody Business (2020-2025)
11.1.5 Bioprojet SCR Recent Development
11.2 Novartis International AG
11.2.1 Novartis International AG Company Details
11.2.2 Novartis International AG Business Overview
11.2.3 Novartis International AG Anti-Neprilysin Antibody Introduction
11.2.4 Novartis International AG Revenue in Anti-Neprilysin Antibody Business (2020-2025)
11.2.5 Novartis International AG Recent Development
11.3 Pharmaleads SA
11.3.1 Pharmaleads SA Company Details
11.3.2 Pharmaleads SA Business Overview
11.3.3 Pharmaleads SA Anti-Neprilysin Antibody Introduction
11.3.4 Pharmaleads SA Revenue in Anti-Neprilysin Antibody Business (2020-2025)
11.3.5 Pharmaleads SA Recent Development
11.4 Theravance Biopharma Inc.
11.4.1 Theravance Biopharma Inc. Company Details
11.4.2 Theravance Biopharma Inc. Business Overview
11.4.3 Theravance Biopharma Inc. Anti-Neprilysin Antibody Introduction
11.4.4 Theravance Biopharma Inc. Revenue in Anti-Neprilysin Antibody Business (2020-2025)
11.4.5 Theravance Biopharma Inc. Recent Development
11.5 Cipla Limited
11.5.1 Cipla Limited Company Details
11.5.2 Cipla Limited Business Overview
11.5.3 Cipla Limited Anti-Neprilysin Antibody Introduction
11.5.4 Cipla Limited Revenue in Anti-Neprilysin Antibody Business (2020-2025)
11.5.5 Cipla Limited Recent Development
11.6 Oceanic Pharmachem Pvt. Ltd
11.6.1 Oceanic Pharmachem Pvt. Ltd Company Details
11.6.2 Oceanic Pharmachem Pvt. Ltd Business Overview
11.6.3 Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Antibody Introduction
11.6.4 Oceanic Pharmachem Pvt. Ltd Revenue in Anti-Neprilysin Antibody Business (2020-2025)
11.6.5 Oceanic Pharmachem Pvt. Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Bioprojet SCR
Novartis International AG
Pharmaleads SA
Theravance Biopharma Inc
Cipla Ltd
Oceanic Pharmachem Pvt. Ltd
List of Tables
 Table 1. Global Anti-Neprilysin Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Sacubitril
 Table 3. Key Players of TD-0714
 Table 4. Key Players of STR-324
 Table 5. Key Players of PL-265
 Table 6. Key Players of LHW-090
 Table 7. Global Anti-Neprilysin Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Anti-Neprilysin Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Anti-Neprilysin Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Anti-Neprilysin Antibody Market Share by Region (2020-2025)
 Table 11. Global Anti-Neprilysin Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Anti-Neprilysin Antibody Market Share by Region (2026-2031)
 Table 13. Anti-Neprilysin Antibody Market Trends
 Table 14. Anti-Neprilysin Antibody Market Drivers
 Table 15. Anti-Neprilysin Antibody Market Challenges
 Table 16. Anti-Neprilysin Antibody Market Restraints
 Table 17. Global Anti-Neprilysin Antibody Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Anti-Neprilysin Antibody Market Share by Players (2020-2025)
 Table 19. Global Top Anti-Neprilysin Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Neprilysin Antibody as of 2024)
 Table 20. Ranking of Global Top Anti-Neprilysin Antibody Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Anti-Neprilysin Antibody Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Anti-Neprilysin Antibody, Headquarters and Area Served
 Table 23. Global Key Players of Anti-Neprilysin Antibody, Product and Application
 Table 24. Global Key Players of Anti-Neprilysin Antibody, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Anti-Neprilysin Antibody Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Anti-Neprilysin Antibody Revenue Market Share by Type (2020-2025)
 Table 28. Global Anti-Neprilysin Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Anti-Neprilysin Antibody Revenue Market Share by Type (2026-2031)
 Table 30. Global Anti-Neprilysin Antibody Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Anti-Neprilysin Antibody Revenue Market Share by Application (2020-2025)
 Table 32. Global Anti-Neprilysin Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Anti-Neprilysin Antibody Revenue Market Share by Application (2026-2031)
 Table 34. North America Anti-Neprilysin Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Anti-Neprilysin Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Anti-Neprilysin Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Anti-Neprilysin Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Anti-Neprilysin Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Anti-Neprilysin Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Anti-Neprilysin Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Anti-Neprilysin Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Anti-Neprilysin Antibody Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Anti-Neprilysin Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Anti-Neprilysin Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Anti-Neprilysin Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Anti-Neprilysin Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Anti-Neprilysin Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Anti-Neprilysin Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Bioprojet SCR Company Details
 Table 50. Bioprojet SCR Business Overview
 Table 51. Bioprojet SCR Anti-Neprilysin Antibody Product
 Table 52. Bioprojet SCR Revenue in Anti-Neprilysin Antibody Business (2020-2025) & (US$ Million)
 Table 53. Bioprojet SCR Recent Development
 Table 54. Novartis International AG Company Details
 Table 55. Novartis International AG Business Overview
 Table 56. Novartis International AG Anti-Neprilysin Antibody Product
 Table 57. Novartis International AG Revenue in Anti-Neprilysin Antibody Business (2020-2025) & (US$ Million)
 Table 58. Novartis International AG Recent Development
 Table 59. Pharmaleads SA Company Details
 Table 60. Pharmaleads SA Business Overview
 Table 61. Pharmaleads SA Anti-Neprilysin Antibody Product
 Table 62. Pharmaleads SA Revenue in Anti-Neprilysin Antibody Business (2020-2025) & (US$ Million)
 Table 63. Pharmaleads SA Recent Development
 Table 64. Theravance Biopharma Inc. Company Details
 Table 65. Theravance Biopharma Inc. Business Overview
 Table 66. Theravance Biopharma Inc. Anti-Neprilysin Antibody Product
 Table 67. Theravance Biopharma Inc. Revenue in Anti-Neprilysin Antibody Business (2020-2025) & (US$ Million)
 Table 68. Theravance Biopharma Inc. Recent Development
 Table 69. Cipla Limited Company Details
 Table 70. Cipla Limited Business Overview
 Table 71. Cipla Limited Anti-Neprilysin Antibody Product
 Table 72. Cipla Limited Revenue in Anti-Neprilysin Antibody Business (2020-2025) & (US$ Million)
 Table 73. Cipla Limited Recent Development
 Table 74. Oceanic Pharmachem Pvt. Ltd Company Details
 Table 75. Oceanic Pharmachem Pvt. Ltd Business Overview
 Table 76. Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Antibody Product
 Table 77. Oceanic Pharmachem Pvt. Ltd Revenue in Anti-Neprilysin Antibody Business (2020-2025) & (US$ Million)
 Table 78. Oceanic Pharmachem Pvt. Ltd Recent Development
 Table 79. Research Programs/Design for This Report
 Table 80. Key Data Information from Secondary Sources
 Table 81. Key Data Information from Primary Sources
 Table 82. Authors List of This Report


List of Figures
 Figure 1. Anti-Neprilysin Antibody Picture
 Figure 2. Global Anti-Neprilysin Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Anti-Neprilysin Antibody Market Share by Type: 2024 VS 2031
 Figure 4. Sacubitril Features
 Figure 5. TD-0714 Features
 Figure 6. STR-324 Features
 Figure 7. PL-265 Features
 Figure 8. LHW-090 Features
 Figure 9. Global Anti-Neprilysin Antibody Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Anti-Neprilysin Antibody Market Share by Application: 2024 VS 2031
 Figure 11. Hospital Pharmacies Case Studies
 Figure 12. Retail Pharmacies Case Studies
 Figure 13. Online Pharmacies Case Studies
 Figure 14. Anti-Neprilysin Antibody Report Years Considered
 Figure 15. Global Anti-Neprilysin Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Anti-Neprilysin Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Anti-Neprilysin Antibody Market Share by Region: 2024 VS 2031
 Figure 18. Global Anti-Neprilysin Antibody Market Share by Players in 2024
 Figure 19. Global Top Anti-Neprilysin Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Neprilysin Antibody as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Anti-Neprilysin Antibody Revenue in 2024
 Figure 21. North America Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Anti-Neprilysin Antibody Market Share by Country (2020-2031)
 Figure 23. United States Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Anti-Neprilysin Antibody Market Share by Country (2020-2031)
 Figure 27. Germany Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Anti-Neprilysin Antibody Market Share by Region (2020-2031)
 Figure 35. China Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Anti-Neprilysin Antibody Market Share by Country (2020-2031)
 Figure 43. Mexico Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Anti-Neprilysin Antibody Market Share by Country (2020-2031)
 Figure 47. Turkey Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Anti-Neprilysin Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Bioprojet SCR Revenue Growth Rate in Anti-Neprilysin Antibody Business (2020-2025)
 Figure 51. Novartis International AG Revenue Growth Rate in Anti-Neprilysin Antibody Business (2020-2025)
 Figure 52. Pharmaleads SA Revenue Growth Rate in Anti-Neprilysin Antibody Business (2020-2025)
 Figure 53. Theravance Biopharma Inc. Revenue Growth Rate in Anti-Neprilysin Antibody Business (2020-2025)
 Figure 54. Cipla Limited Revenue Growth Rate in Anti-Neprilysin Antibody Business (2020-2025)
 Figure 55. Oceanic Pharmachem Pvt. Ltd Revenue Growth Rate in Anti-Neprilysin Antibody Business (2020-2025)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Anti Neprilysin Market Research Report 2024
Global Natriuretic Peptide Market Research Report 2025
Global Brain Natriuretic Peptide Antibody Market Research Report 2024
Global Neurokinin Receptor Antagonists API Market Research Report 2024
Global Bestatin Market Research Report 2024
Global Kallikrein Inhibitors Market Research Report 2024
Global Leupeptin Market Research Report 2024
Global Brain Natriuretic Peptide Monoclonal Antibody Market Research Report 2024
Vasopressin Antagonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bradykinin Receptor Antagonists Market Research Report 2024
Global Neurokinin Receptor Antagonists Market Research Report 2024
Global Pepstatin A Market Research Report 2024
Global Brain Natriuretic Peptide BNP ELISA Kit Market Research Report 2024
Endothelin Antagonists Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global N terminal Pro B type Natriuretic Peptide Market Insights Forecast to 2030
Global Neurotensin Market Research Report 2024
Global Enterokinase Market Research Report 2025
Global Neuraminidase Inhibitor Market Research Report 2024
Global Therapeutic Peptide APIs Market Research Report 2024
Global Anti Neuropilin 1 Antibody Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions